The aim of this study was to measure the levels of circulating BDNF and the frequency of BDNF-producing T cells after acute ischaemic stroke. Serum BDNF levels were measured by ELISA. Flow cytometry was used to enumerate peripheral blood leukocytes that were labelled with antibodies against markers of T cells, T regulatory cells (Tregs), and intracellular BDNF. There was a slight increase in serum BDNF levels after stroke. There was no overall difference between stroke patients and controls in the frequency of CD4 + and CD8 + BDNF + cells, although a subgroup of stroke patients showed high frequencies of these cells. However, there was an increase in the percentage of BDNF + Treg cells in the CD4 + population in stroke patients compared to controls. Patients with high percentages of CD4 + BDNF + Treg cells had a better outcome at 6 months than those with lower levels.
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These groups did not differ in age, gender or initial stroke severity. Enhancement of BDNF production after stroke could be a useful means of improving neuroprotection and recovery after stroke. © 2015 Elsevier B.V. All rights reserved.
Introduction
Ischemic stroke is caused by interruption of supply of blood to a part of the brain, creating an environment of hypoxia and glucose deprivation that leads to neuronal death and neurological deficits (Moustafa and Baron, 2008) . After stroke there is local inflammation at the site of injury (Gelderblom et al., 2009) , which can be harmful in the early stages since activation of microglial cells and local inflammatory responses exacerbate injury to the brain (Jin et al., 2010) . There is also systemic immune activation after stroke (Yan et al., 2009 ). We have previously reported that stroke subjects have increased levels of circulating anti-inflammatory cytokines (Yan et al., 2012a) and upregulation of CD4 + CD25
hi Foxp3 + T regulatory cells (Tregs) after stroke (Yan et al., 2012b) . The increase in anti-inflammatory cytokines and the increased frequency of circulating Tregs could serve to reduce harmful inflammation. However, the overall effects of the systemic activation of the immune system after stroke are complex and may include beneficial effects (McCombe and Read, 2008; Yilmaz et al., 2006) . Beneficial effects of the immune response after stroke could be mediated by protective immunity, which plays a role in recovery from injury and which is mediated through Tregs. Tregs have the functions of negative regulation of immune responses, self-tolerance and control of damage at the site of inflammation (Tang and Bluestone, 2008; Wan, 2010) . In experimental stroke, the absence of Tregs in mice caused elevated expression of pro-inflammatory cytokines, indicating the role of Tregs in protection in acute ischemic stroke (Liesz et al., 2009 ). Adoptive transfer of Treg cells led to reduction of volume of ischaemia in experimental stroke (Brea et al., 2014) . However, the role of Treg cells in recovery from stroke may be different at different time points after stroke (Chen et al., 2013; Kleinschnitz et al., 2013; Xu et al., 2013) .
Neurotrophins are molecules that promote the growth and survival of neurons (Huang and Reichardt, 2001) . One important neurotrophin is brain derived neurotrophic factor (BDNF) which improves neuronal survival and prevents neuronal death by activating intracellular protein kinases B and mitogen-activated protein kinases (MAPK/ERK) (Schabitz et al., 2000) . Administration of BDNF in regional brain ischemia caused both a reduction in stroke volume and an improvement in functional outcome (Zhang and Pardridge, 2006) . There is only one study of circulating levels of BDNF after stroke, which found no increase in BDNF levels in 10 stroke subjects sampled at admission and daily for the following four days (Di Lazzaro et al., 2007) .
However, even if circulating levels are unchanged, another possibility is that Tregs could deliver neurotrophins, such as BDNF, to the site of injury, and these could assist in recovery (Greenberg et al., 2009) . It is known that activated human T cells, B cells and monocytes secrete Journal of Neuroimmunology 286 (2015) 42-47 
